Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Bullboard - Stock Discussion Forum Arch Biopartners Inc V.ARCH

Alternate Symbol(s): ACHFF

Technology Scientific & Technical Instruments

Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is... see more

Add To Watchlist

Bullboard (TSXV:ARCH)

View:

Post by Riverfolkon Sep 14, 2021 6:04pm

BLU - Positive Phase 2 results / Market Cap

https://www.stockwatch.com/News/Item/Z-C!BLU-3139110/C/BLU BLU - Market Cap - 472 million - Cronic Cough ARCH - Market Cap - 106 Million - Organ Inflammation

180

Discussion

Post by Riverfolkon Sep 09, 2021 9:58am

Human Clinical Trial Results Pending 3rd Party Review - DD

Here is the science published by a world renounced third party: Dipeptidase-1 ( Metablok) mice, with survival increasing from 0% to 83% Here is the technology developer and CSO explaining ...more

803

Lahontan Gold Announces Filing of Santa Fe Technical Report

posted Nov 29, 2024 9:00am by Lahontan Gold Corp.

Lahontan Gold is pleased to announce that the Company has filed on SEDAR+ an independent Technical Report and updated Mineral Resource Estimate ("MRE") titled "Santa Fe Project Technical Report," effective October 9, 2024, and dated November 27, 2024, for Lahontan's Santa Fe Mine gold and silver project, Santa Fe District, Mineral County, Nevada. ...read more

Post by 2019champson Sep 09, 2021 8:00am

The money is in metablok, not ivermectin and others

Over the last several months, ivermectin has come up as a potential treatment for covid. The problem with that is, ivermectin is such a cheap treatment. No matter how effective it is, mainstream media ...more

173

Comment by Antonius2on Sep 09, 2021 1:06am

RE:RE:SrPlata

Welcome to the board SrPlata, judging from your posts - you look like you will fit in this group nicely. Thank you for your 10 points.

Discussion

Comment by SrPlataon Sep 09, 2021 12:14am

RE:Insider ownership

yes plus what his brother holds, not sure how much he owns, but I am assuming it is well over 5% seeing he was one of the founders. Another positive is the company is very conservative in giving ...more

101

Discussion

Post by TheBearInTheWoodson Sep 08, 2021 11:52pm

Insider ownership

You are correct with the 55 percent insider ownership but the CEO alone controls 14% and was a buyer last year in the 1.40s

152

Discussion

Comment by SrPlataon Sep 08, 2021 11:51pm

RE:SrPlata

Thanks for your warm welcome. I normally don't post alot just mainly read what others post but I made an exception with Arch. Why? first off this is the most polite message board I have ever seen. ...more

Discussion

Comment by TheBearInTheWoodson Sep 08, 2021 11:41pm

RE:RE:RE:RE:Why the little guy has the advantage in Arch Bio continued

The webinar from last year had the chief science officer talk about additional drug technology to come and with patents. The most important thing is that Arch has a NEW MECHANISM OF ACTION!! Look at ...more

Discussion

Comment by SrPlataon Sep 08, 2021 11:28pm

RE:RE:RE:Why the little guy has the advantage in Arch Bio continued

You are right on with your analysis. One of the most positive things you mentioned is the heavy insider ownership around 55%. Thats nice some may say, but why in this situation is it so bullish ...more

Discussion

Comment by TheBearInTheWoodson Sep 08, 2021 11:25pm

RE:RE:RE:Why the little guy has the advantage in Arch Bio continued

You are correct about funding up till this date, every financing since I have been a shareholder has been from 1 or 2 placees as a bought deal or convertible with out warrants

Discussion

Post by TheBearInTheWoodson Sep 08, 2021 11:19pm

SrPlata

Welcome to the board! It is great to read your enthusiasm, as most of us on this board have been on here for years. I can speak to the record and execution this team has performed, as the guy ...more

105

Discussion

Comment by SrPlataon Sep 08, 2021 9:14pm

RE:RE:Why the little guy has the advantage in Arch Bio continued

I agree with you. I built my position after doing a deep dive on due diligence and the deeper I went the more I bought. I could not get over they got as far as they have come with out any Wall ...more

Discussion

Comment by SrPlataon Sep 08, 2021 7:08pm

RE:Looks like we have American IR

Why did RM bring in Michael Bayes of Redwood Empire in early June 2021? This in my oppinion was to get the word out to the American investors about this little gem. I know Michael and he is not a ...more

Discussion

Comment by Cb27743on Sep 08, 2021 6:40pm

RE:RE:Why the little guy has the advantage in Arch Bio continued

Very bullish for Arch. With the Delta variant currently present and the global Covid-19 cases expected to rise in the next coming months. A therapeutic drug that will target the inflammatory response ...more

Discussion

The Market Update

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

< Previous

Next >

Dealroom for high-potential pre-IPO opportunities

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard - Stock Discussion Forum Arch Biopartners Inc V.ARCH

Alternate Symbol(s): ACHFF

Join the community and start posting on the bullboards today. It's free.

Create a portfolio watchlist today. It's free.

Bullboard (TSXV:ARCH)